ECONSALUD Archivos

Economía de la Salud

ECONSALUD@LISTSERV.REDIRIS.ES

Opciones: Vista Forum

Use Monospaced Font
Por defecto enseñar Text Part
Mostrar todas las cabeceras de correo

Mensaje: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Tema: [<< Primero] [< Prev] [Siguiente >] [Último >>]
Autor: [<< Primero] [< Prev] [Siguiente >] [Último >>]

Print Responder
Subject:
Emisor:
AES ECONSALUD <[log in para visualizar]>
Reply To:
Economía de la Salud <[log in para visualizar]>
Fecha:
Mon, 6 Apr 2020 20:09:44 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (6 lines)
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine 

A COVID-19 vaccine is needed now, but timelines (12-18 months) create large market risk. By the time a vaccine is ready, the crisis may have passed. A CGD Note explores three options: business as usual – which may lead to promotion of an inferior vaccine or fierce country competition for supply – and two models (cost- or value-based), with countries pre-committing to purchases meeting specified efficacy. The authors prefer a value-based model.

Available at: https://www.ohe.org/news/financing-and-scaling-innovation-covid-fight-closer-look-demand-side-incentives-vaccine

ATOM RSS1 RSS2